- Home
- GPATU vs GALT Comparison
GPATU vs GALT Comparison
Compare GPATU & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPATU
- GALT
- Stock Information
- Founded
- GPATU N/A
- GALT 2000
- Country
- GPATU
- GALT United States
- Employees
- GPATU N/A
- GALT N/A
- Industry
- GPATU
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- GPATU
- GALT Health Care
- Exchange
- GPATU NYSE
- GALT Nasdaq
- Market Cap
- GPATU N/A
- GALT 147.8M
- IPO Year
- GPATU N/A
- GALT N/A
- Fundamental
- Price
- GPATU $10.20
- GALT $1.04
- Analyst Decision
- GPATU
- GALT Strong Buy
- Analyst Count
- GPATU 0
- GALT 1
- Target Price
- GPATU N/A
- GALT $11.00
- AVG Volume (30 Days)
- GPATU N/A
- GALT 1.1M
- Earning Date
- GPATU N/A
- GALT 11-13-2024
- Dividend Yield
- GPATU N/A
- GALT N/A
- EPS Growth
- GPATU N/A
- GALT N/A
- EPS
- GPATU N/A
- GALT N/A
- Revenue
- GPATU N/A
- GALT N/A
- Revenue This Year
- GPATU N/A
- GALT N/A
- Revenue Next Year
- GPATU N/A
- GALT N/A
- P/E Ratio
- GPATU N/A
- GALT N/A
- Revenue Growth
- GPATU N/A
- GALT N/A
- 52 Week Low
- GPATU N/A
- GALT $0.73
- 52 Week High
- GPATU N/A
- GALT $4.27
- Technical
- Relative Strength Index (RSI)
- GPATU N/A
- GALT 20.80
- Support Level
- GPATU N/A
- GALT $1.80
- Resistance Level
- GPATU N/A
- GALT $2.36
- Average True Range (ATR)
- GPATU 0.00
- GALT 0.27
- MACD
- GPATU 0.00
- GALT -0.08
- Stochastic Oscillator
- GPATU 0.00
- GALT 15.07
About GPATU GP-ACT III ACQUISITION CORP
GP-Act III Acquisition Corp is a blank check company.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.